Figure 6
From: Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Detection of lectin-reactive glycans on α-1-acid glycoprotein (AGP) using recombinant lectin array chip. The AGP concentration adjusted lectin array analysis showed that terminal α2.3 sialylated glycan (A), α2.6 sialylated glycan (B), and terminal galactose (C), were significantly increased in the CRPC patients. In contrast, branched-LacNAc structure was significantly decreased in the CRPC patients (D). RFI: Relative fluorescent intensity.
